One of the main disadvantages of a long GnRH agonist protocol is the higher risk of OHSS [1, 12] as well as the impossibility of triggering final follicular maturation with a GnRH agonist instead of administration of hCG [4]. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.